1. Kolářová H, Tesařová M, Švecová Š, Stránecký V, Přistoupilová A, Zima T, et al. Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene. Folia Biol (Praha). 2014; 60:235–243. PMID:
25863041.
2. Rahalkar AR, Giffen F, Har B, Ho J, Morrison KM, Hill J, et al. Novel
LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review. Can J Physiol Pharmacol. 2009; 87:151–160. PMID:
19295657.
3. Ooi EM, Russell BS, Olson E, Sun SZ, Diffenderfer MR, Lichtenstein AH, et al. Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations. Arterioscler Thromb Vasc Biol. 2012; 32:459–466. PMID:
22095987.
4. Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P. Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75% are clustered in exons 5 and 6. Ann Genet. 2001; 44:25–32. PMID:
11334614.
6. Peterson J, Ayyobi AF, Ma Y, Henderson H, Reina M, Deeb SS, et al. Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene. J Lipid Res. 2002; 43:398–406. PMID:
11893776.
7. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 1999; 99:2901–2907. PMID:
10359734.
8. Goldberg IJ, Eckel RH, McPherson R. Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol. 2011; 31:1716–1725. PMID:
21527746.
9. Scott LJ. Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency. Drugs. 2015; 75:175–182. PMID:
25559420.
10. Kniery KR, Kay JT, Escobar MA. The fatty spleen: Severe hypertriglyceridemia leading to splenomegaly in a child. J Pediatr Surg Case Rep. 2017; 17:25–27.